Patents by Inventor Kunrong Cheng

Kunrong Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER WITH ANTI-MUSCARINIC RECEPTOR AGENTS
    Publication number: 20090010923
    Abstract: The present invention relates to methods of treating proliferative disorders of colon cells. The methods comprise administering to the cells an effective amount of at least one agent to reduce M3 muscarinic receptor-mediated transactivation of at least one epidermal growth factor receptor.
    Type: Application
    Filed: April 24, 2008
    Publication date: January 8, 2009
    Applicant: University of Maryland, Baltimore
    Inventors: Jean-Pierre Raufman, Kunrong Cheng, Jasleen Shant, Guofeng Xie, Sandeep Khurana
  • Hybrid cholinergic agents and compositions
    Patent number: 6624155
    Abstract: The present invention provides hybrid molecules and methods of synthesizing such hybrid molecules from a cholinergic agent and a bile acid. The hybrid molecules function as cholinergic agents and may be either cholinergic agonists or cholinergic antagonists. Further disclosed herein are compositions comprising hybrid cholinergic agents and methods of making such compositions. Methods of treating a patient having a cholinergic disorder are also disclosed.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: September 23, 2003
    Assignee: Board of Trustees of the University of Arkansas
    Inventors: Jean-Pierre Raufman, Piotr Zimniak, Kunrong Cheng
  • Methods of making and method of using hybrid cholinergic agents and compositions
    Patent number: 6624156
    Abstract: The present invention provides hybrid molecules and methods of synthesizing such hybrid molecules from a cholinergic agent and a bile acid. The hybrid molecules function as cholinergic agents and may be either cholinergic agonists or cholinergic antagonists. Further disclosed herein are compositions comprising hybrid cholinergic agents and methods of making such compositions. Methods of treating a patient having a cholinergic disorder are also disclosed.
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: September 23, 2003
    Assignee: Board of Trustees of the University of Arkansas
    Inventors: Jean-Pierre Raufman, Piotr Zimniak, Kunrong Cheng
  • Hybrid cholinergic agents and compositions, methods of making, and methods of using to treat a cholinergic disorder
    Publication number: 20020187971
    Abstract: The present invention provides hybrid molecules and methods of synthesizing such hybrid molecules from a cholinergic agent and a bile acid. The hybrid molecules function as cholinergic agents and may be either cholinergic agonists or cholinergic antagonists. Further disclosed herein are compositions comprising hybrid cholinergic agents and methods of making such compositions. Methods of treating a patient having a cholinergic disorder are also disclosed.
    Type: Application
    Filed: May 1, 2001
    Publication date: December 12, 2002
    Inventors: Jean-Pierre Raufman, Piotr Zimniak, Kunrong Cheng
  • Methods of making and method of using hybrid cholinergic agents and compositions
    Publication number: 20020183295
    Abstract: The present invention provides hybrid molecules and methods of synthesizing such hybrid molecules from a cholinergic agent and a bile acid. The hybrid molecules function as cholinergic agents and may be either cholinergic agonists or cholinergic antagonists. Further disclosed herein are compositions comprising hybrid cholinergic agents and methods of making such compositions. Methods of treating a patient having a cholinergic disorder are also disclosed.
    Type: Application
    Filed: June 25, 2002
    Publication date: December 5, 2002
    Inventors: Jean-Pierre Raufman, Piotr Zimniak, Kunrong Cheng